Form 4 for TXG 10x Genomics, Inc.
Accepted 2026-08-24 16:16:39 ET · period of report 2026-08-20 · accession 0001610717-26-000386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 16:16 | 2026-08-20 | TXG | Saxonov Serge | CEO, Dir | G - Gift | $0.00 | -4,000 | 1.10M | -0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-08-20 | G | D | 4,000 | $0.00 | 1,104,380 | D | — | — |